Does REPAGLINIDE Cause Off label use? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Off label use have been filed in association with REPAGLINIDE (Repaglinide). This represents 2.0% of all adverse event reports for REPAGLINIDE.
51
Reports of Off label use with REPAGLINIDE
2.0%
of all REPAGLINIDE reports
3
Deaths
32
Hospitalizations
How Dangerous Is Off label use From REPAGLINIDE?
Of the 51 reports, 3 (5.9%) resulted in death, 32 (62.7%) required hospitalization, and 2 (3.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does REPAGLINIDE Cause?
Hypoglycaemia (665)
Acute kidney injury (281)
Lactic acidosis (163)
Hypoglycaemic coma (125)
Sopor (91)
Confusional state (89)
Drug interaction (89)
Blood glucose increased (88)
Diarrhoea (87)
Dyspnoea (87)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REPAGLINIDE Alternatives Have Lower Off label use Risk?
REPAGLINIDE vs REPOTRECTINIB
REPAGLINIDE vs REQUIP
REPAGLINIDE vs RESLIZUMAB
REPAGLINIDE vs RESMETIROM
REPAGLINIDE vs RESTASIS